Glooko

Diabnext is a digital diabetes management company based in Paris, Ile-de-France, that offers a comprehensive application aimed at improving the management of pre-diabetes and diabetes. The application combines hardware and software to automate the logging of insulin units and blood glucose levels, enhancing the self-monitoring process for patients. It facilitates injection follow-ups and provides tools for remote monitoring, enabling healthcare professionals to track and educate patients more effectively. By offering features such as reminders for blood glucose checks and medication, Diabnext aims to empower patients in managing their condition while also addressing the medico-economic burden associated with diabetes-related complications. The data generated by the application is accessible to both patients and their healthcare providers, promoting better coordination in diabetes care.

xbird GmbH is a medical artificial intelligence company headquartered in Berlin, Germany, founded in 2015. The company specializes in developing software solutions that utilize algorithms to analyze micro-movements detected by sensors in smartphones and wearables. These algorithms interpret daily activities and significant events affecting patients' health, particularly in the context of diabetes management. By capturing data related to patients' behavior and lifestyles, xbird aims to personalize therapies, identify potential health risks, and optimize long-term treatment outcomes. The company's innovative approach contributes to holistic care in the healthcare sector, enhancing the ability of caregivers to monitor and support patients effectively.

Diasend AB is a Swedish company that specializes in diabetes data management, offering solutions for both patients and healthcare providers. The diasend system allows for the uploading, consolidation, and reporting of data from over 140 different devices, including glucose meters, insulin pumps, and continuous glucose monitors. With products like diasend Clinic and diasend Personal, the company facilitates efficient data collection and storage for healthcare providers and individuals with diabetes, respectively. Additionally, its EMR interface enables seamless interoperability by integrating diabetes data into healthcare providers' electronic medical records. Founded in 2004 and formerly known as Aidera AB, Diasend is headquartered in Askim, Sweden, with additional locations in Chicago, Illinois, and Barcelona, Spain. As of 2016, Diasend operates as a subsidiary of Glooko, Inc., and its FDA-approved and CE-marked solutions are utilized in 23 countries.

Glooko is a company that develops a remote patient-monitoring platform specifically designed for individuals with diabetes. This platform integrates with various diabetes devices, fitness wearables, and activity trackers to capture and sync health data. It provides comprehensive reports and analytics aimed at promoting behavior change and improving health outcomes. By enhancing communication between patients and healthcare providers, Glooko facilitates better management of diabetes and supports remote monitoring efforts. The platform is accessible on both Android and iOS devices, allowing users to conveniently track their diabetes-related information on their smartphones.